(RTTNews) - RedHill Biopharma Ltd. (RDHL) Monday said the U.S. Patent and Trademark Office (USPTO) has granted new patent for Talicia indicated for the treatment of Helicobacter pylori (H. pylori) ...
Several Twitter users on Thursday, November 25, took to the micro-blogging site to narrate their experiences with bacteria Helicobacter pylori (H. Pylori). The users observed that H. Pylori seems to ...
In a study of H pylori reinfection from patients' spouses, Shutze and colleagues [9] noted that 10 of 16 duodenal ulcer patients who had not been reinfected developed reflux esophagitis during the ...
Expert Rev Anti Infect Ther. 2007;5(5):845-856. The optimal strategy for second-line therapy associates PPI with amoxicillin and metronidazole or PPI with tetracycline and metronidazole, with a ...
H pylori infection The applications are based on data from the phase 3 PHALCON-HP trial. The New Drug Applications for vonoprazan triple therapy (in combination with amoxicillin and clarithromycin) ...
The Trump administration killed a federal report on alcohol and health risks, the draft of which concluded that moderate drinking could increase the risks for liver disease and cancer. (New York Times ...
In a recent study published in BMC Infectious Diseases, researchers explored the eradication rates of Helicobacter pylori utilizing levofloxacin and clarithromycin-based regimens in patients with ...
The FDA approved two vonoprazan-based regimens, one with amoxicillin and clarithromycin (Voquezna Triple Pak), and one with amoxicillin (Voquezna Dual Pak), to treat Helicobacter pylori (H. pylori) ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. An error has occurred. Please try again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback